TRGAted: A web tool for survival analysis using protein data in the Cancer Genome Atlas. [version 1; referees: 2 approved]

• Main Authors: Nicholas Borcherding, Nicholas L. Bormann, Andrew P. Voigt, Weizhou Zhang
• Format: Article
• Language: English
• Published: F1000 Research Ltd 2018-08-01
• Series: F1000Research
• Online Access: https://f1000research.com/articles/7-1235/v1

Reverse-phase protein arrays (RPPAs) are a highthroughput approach to protein quantification utilizing an antibody-based micro-to-nano scale dot blot. Within the Cancer Genome Atlas (TCGA), RPPAs were used to quantify over 200 proteins in 8,167 tumor or metastatic samples. This protein-level data has particular advantages in assessing putative prognostic or therapeutic targets in tumors. However, many of the available pipelines do not allow for the partitioning of clinical and RPPA information to make meaningful conclusions. We developed a cloud-based application, TRGAted to enable researchers to better examine survival based on single or multiple proteins across 31 cancer types in the TCGA. TRGAted contains up-to-date overall survival, disease-specific survival, disease-free interval and progression-free interval information. Furthermore, survival information for primary tumor samples can be stratified based on gender, age, tumor stage, histological type, and subtype, allowing for highly adaptive and intuitive user experience. The code and processed data is open sourced and available on github  and with a tutorial built into the application for assisting users.